224 related articles for article (PubMed ID: 18544037)
21. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
Van Der Wielen M; Van Damme P; Collard F
Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
[TBL] [Abstract][Full Text] [Related]
22. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
[TBL] [Abstract][Full Text] [Related]
23. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in healthy Chilean subjects.
Prado V; Riedemann S; Ibarra H; Potin M
Int J Infect Dis; 2002 Jun; 6(2):129-33. PubMed ID: 12121601
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
26. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
[TBL] [Abstract][Full Text] [Related]
28. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
Van Herck K; Van Damme P; Collard F; Thoelen S
Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
[TBL] [Abstract][Full Text] [Related]
29. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
[TBL] [Abstract][Full Text] [Related]
30. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
Burgess MA; Rodger AJ; Waite SA; Collard F
Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of the immunogenicity of combined hepatitis A and B vaccine by a prospective and retrospective trial.
Wolters B; Müller T; Ross RS; Clauberg R; Werfel U; Roggendorf H; Siggelkow C; Hausen T; Roggendorf M
Hum Vaccin; 2009 Apr; 5(4):248-53. PubMed ID: 19276678
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
[TBL] [Abstract][Full Text] [Related]
33. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
34. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
[TBL] [Abstract][Full Text] [Related]
35. Antibody persistence six years after two doses of combined hepatitis A and B vaccine.
Burgess MA; McIntyre PB; Hellard M; Ruff TA; Lefevre I; Bock HL
Vaccine; 2010 Mar; 28(10):2222-2226. PubMed ID: 20056187
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children.
Guptan RC; Thakur V; Safary A; Sarin SK
Vaccine; 2002 May; 20(16):2102-6. PubMed ID: 11972979
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?
Jimenez HR; Hallit RR; Debari VA; Slim J
Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097
[TBL] [Abstract][Full Text] [Related]
39. Response to hepatitis A and B vaccination in patients with chronic hepatitis C: 8-year follow-up.
Kalyoncu D; Urganci N
Paediatr Int Child Health; 2012 Aug; 32(3):136-9. PubMed ID: 22824660
[TBL] [Abstract][Full Text] [Related]
40. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years.
Levie K; Beran J; Collard F; Nguyen C
Vaccine; 2002 Jun; 20(19-20):2579-84. PubMed ID: 12057615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
